MENU

Celgene Aktie (NASDAQ:CELG)

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

{{ formattedPrice }} {{ change }} (-3,74 %)

Quotes delayed. Last trade: 07-12-2018, 10:00:00pm CET

CELG vs. S&P 500
Eröffnung {{ openPrice }} Schlusskurs {{ closePrice }}
Tages-Hoch {{ high }} Tages-Tief {{ low }}
Geld {{ bid }} Brief {{ ask }}
Volumen 6601681    

Related Articles